Get started
000

JW PHARMACEUTICAL

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

001060 chart


Full chart

001060 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪560.29 B‬ KRW
Dividend yield (indicated)
1.61%
Price to earnings Ratio (TTM)
0
Basic EPS (TTM)
3,000 KRW
Net income (FY)
‪35.10 B‬ KRW
Revenue (FY)
‪748.53 B‬ KRW
Shares float
‪11.78 M‬
Beta (1Y)
1.03

Employees


Employees (FY)
‪1.15 K‬
Revenue / Employee (1Y)
‪499.45 K‬ KRW
Net income / Employee (1Y)
‪23.42 K‬ KRW

About JW PHARMACEUTICAL


Sector
Health Technology
Headquarters
Seoul
Founded
1945
Website
jw-pharma.co.kr
ISIN
KR7001060003
FIGI
BBG000BDFM85
JW PHARMACEUTICAL Corp. engages in the development, manufacture, and sale of pharmaceuticals. Its products include analgesics, antipyretics and cold remedy, antidote, antimicrobials, anticancer, antifungal, circulatory system, gastrointestinal, miscellaneous, multivitamins, and anti-anemic agents, contact lens care and ophthalmic agents, topicals, amino acid solutions, flexible intravenous container, intravenous solutions, respiratory, obstetrics, gynecology, and nephrology agents, central nervous system, urology agents, and diabetic agents. The company was founded on August 8, 1945 and is headquartered in Seoul, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

001060 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 001060 is 23,650 KRW — it has decreased by −2.87% in the past 24 hours. Watch JW PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange JW PHARMACEUTICAL stocks are traded under the ticker 001060.
001060 stock has fallen by −2.07% compared to the previous week, the month change is a −18.31% fall, over the last year JW PHARMACEUTICAL has showed a −18.64% decrease.
We've gathered analysts' opinions on JW PHARMACEUTICAL future price: according to them, 001060 price has a max estimate of 37,000.00 KRW and a min estimate of 37,000.00 KRW. Watch 001060 chart and read a more detailed JW PHARMACEUTICAL stock forecast: see what analysts think of JW PHARMACEUTICAL and suggest that you do with its stocks.
001060 reached its all-time high on Sep 27, 2016 with the price of 82,900 KRW, and its all-time low was 2,050 KRW and was reached on Oct 23, 2003. View more price dynamics on 001060 chart.
See other stocks reaching their highest and lowest prices.
001060 stock is 2.96% volatile and has beta coefficient of 1.03. Track JW PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is JW PHARMACEUTICAL there?
Today JW PHARMACEUTICAL has the market capitalization of ‪564.47 B‬, it has decreased by −7.66% over the last week.
Yes, you can track JW PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
JW PHARMACEUTICAL is going to release the next earnings report on Apr 7, 2025. Keep track of upcoming events with our Earnings Calendar.
JW PHARMACEUTICAL revenue for the last quarter amounts to ‪186.65 B‬ KRW, despite the estimated figure of ‪186.65 B‬ KRW. In the next quarter, revenue is expected to reach ‪210.65 B‬ KRW.
001060 net income for the last quarter is ‪18.82 B‬ KRW, while the quarter before that showed ‪8.07 B‬ KRW of net income which accounts for 133.18% change. Track more JW PHARMACEUTICAL financial stats to get the full picture.
Yes, 001060 dividends are paid annually. The last dividend per share was 400.00 KRW. As of today, Dividend Yield (TTM)% is 1.62%. Tracking JW PHARMACEUTICAL dividends might help you take more informed decisions.
JW PHARMACEUTICAL dividend yield was 1.10% in 2023, and payout ratio reached 26.08%. The year before the numbers were 1.98% and 28.17% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has ‪1.15 K‬ employees. See our rating of the largest employees — is JW PHARMACEUTICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JW PHARMACEUTICAL EBITDA is ‪116.78 B‬ KRW, and current EBITDA margin is 15.93%. See more stats in JW PHARMACEUTICAL financial statements.
Like other stocks, 001060 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JW PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JW PHARMACEUTICAL technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JW PHARMACEUTICAL stock shows the sell signal. See more of JW PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.